| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ddb5193471ae29da9c0e70c0a51595c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb357e5f6ec35b47657d19d64f51c369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dea3ddfbc0255538478fdd20eb97a49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39de8d678f17af99dc96f2003521647a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-164 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2008-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67dd90dcd577927e67fe35108955b8a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_066735aa8d5a718fda305b3446f3e46e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e33f784fcbca8fca3692be4337777be |
| publicationDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8501427-B2 |
| titleOfInvention |
Factor H polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration |
| abstract |
The invention relates to antibodies, including monoclonal and polyclonal, or fragments thereof, which discriminate between the histidine and tyrosine isoforms of Complement Factor H and to their use in diagnostic methods and therapeutic treatments relating to Complement Factor H mediated diseases. |
| priorityDate |
2007-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |